Hemostats Market Share, Growth, Trends and Forecast 2020-2025 | Fortune Business Insights

The report scrutinizes the market by an exhaustive analysis on Global Hemostats Market dynamics, market size, current trends, Forthcoming Developments and Future Investments by Forecast to 2025

The global hemostats market size is anticipated to USD 5.44 billion by the end of 2025. The growth of this region is accountable for the increasing incidences of sports-related injuries worldwide. A hemostat is a surgical tool used for controlling the flow of blood at the time of performing operations. According to a recent report by Fortune Business Insights titled, “Hemostats Market Size, Share & Industry Analysis, By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats, Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Others), By End, User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers, Others) and Regional Forecast, 2018-2025,” the value of this market was USD 3.33 billion in 2017 and is expected to exhibit a CAGR of 6.4% between 2018 and 2025.

Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:

• Biom’up
• Baxter International Inc.
• Medtronic
• Stryker
• Pfizer Inc.
• CryoLife Inc.
• Ethicon LLC
• Integra Life Sciences
• BD
• Other players

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Drivers & Restraints-

Rising Number of Sports Injuries to Augment Growth

The increasing number of accidental cases and the rise in the number of surgical procedures are the major factors promoting hemostat market growth. Additionally, the increasing emphasis on sports and physical activities and the rising number of sports injuries is also expected to aid in the expansion of the market. Besides this, the increasing prevalence of chronic diseases that requires surgical treatment procedures is also adding impetus to the market.

Segment-

Passive Hemostats Segment to Hold Dominance Owing to Improved Patient Outcomes

Based on segmentation by product, the passive hemostats segment earned a 48.1% share in 2017 and gained dominance owing to various advantages offered by this segment. This includes minimal complications, improved patient outcomes, and cost-efficiency.